Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2008-06-04Clinical Trial Update: Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial [Phase 4]
This document reports a completed Phase 4 randomized trial evaluating clozapine augmentation with ziprasidone or risperidone for schizophren…
-
CLINICAL_TRIALS trial_result · 2008-05-21Clinical Trial Update: Switch Study of Existing Atypical Antipsychotics to Bifeprunox [Phase 3]
This update notes the completion of a Phase 3 switch study evaluating transitioning from existing atypical antipsychotics to bifeprunox for …
-
CLINICAL_TRIALS research · 2008-05-21Clinical Trial Update: Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating guanfacine as an adjunct to atypical antipsychotics for cognitive dysfunction in schizophrenia and schizoa…
-
CLINICAL_TRIALS trial_result · 2008-05-15Clinical Trial Update: Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia [Phase 3]
A Phase 3 clinical trial evaluating aripiprazole for acutely relapsed schizophrenia (and schizoaffective disorder) has completed enrollment/…
-
CLINICAL_TRIALS trial_result · 2008-03-18Clinical Trial Update: Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI) [Phase 4]
Phase 4 trial comparing injectable versus oral naltrexone for alcohol dependence in people with serious mental illness has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Glycine to Treat Psychotic Disorders in Children [Phase 2]
Phase 2 clinical trial evaluating glycine for treating psychotic disorders in children has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-27Clinical Trial Update: Supervised Treatment of Schizophrenia, a Randomized Controlled Trial. [Phase 1, Phase 2]
This is a randomized controlled trial update evaluating supervised treatment for schizophrenia in Phase 1 and Phase 2, sponsored by Lady Rea…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin [Phase 4]
Phase 4 clinical trial evaluating whether adding pravastatin to standard treatment improves symptoms in schizophrenia and schizoaffective di…
-
CLINICAL_TRIALS trial_result · 2007-12-13Clinical Trial Update: Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia [Phase 4]
This Phase 4 trial update reports the completion of a study evaluating quetiapine (Seroquel) as therapy for substance use disorders in patie…
-
CLINICAL_TRIALS trial_result · 2007-11-27Clinical Trial Update: Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder [Phase 3]
A Phase 3 trial comparing rapid versus conventional titration of quetiapine in schizophrenia and schizoaffective disorder has been terminate…
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder [Phase 4]
Phase 4 trial comparing continuing olanzapine to switching to quetiapine in overweight or obese adults with schizophrenia or schizoaffective…
-
CLINICAL_TRIALS trial_result · 2007-08-24Clinical Trial Update: Abilify Therapy for Reducing Comorbid Substance Abuse [Phase 4]
Phase 4 trial evaluating aripiprazole (Abilify) for reducing comorbid substance use across multiple psychiatric disorders; the study has com…
-
CLINICAL_TRIALS trial_result · 2007-08-23Clinical Trial Update: Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia [NA]
This clinical trial evaluated whether high-dose B-complex vitamins improve symptoms in schizophrenia and schizoaffective disorder. The study…
-
CLINICAL_TRIALS research · 2007-05-22Clinical Trial Update: AIMHI NT Relapse Prevention Trial [NA]
AIMHI NT Relapse Prevention Trial update (NCT00192582) sponsored by Menzies School of Health Research with listed conditions including schiz…
-
FDA label_change · 2007-04-27FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA (paliperidone) from Janssen Pharmaceuticals, Inc. The approval updates the drug's lab…
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study [Phase 2]
A Phase 2 pilot study evaluating selective estrogen receptor modulators for schizophrenia and related psychotic disorders has completed.
-
CLINICAL_TRIALS research · 2007-02-15Clinical Trial Update: Families Coping With Mental Illness Program [Phase 1]
Phase 1 clinical trial update for the Families Coping With Mental Illness program. The status of the trial is unknown and it concerns schizo…
-
CLINICAL_TRIALS trial_result · 2007-01-29Clinical Trial Update: Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety [Phase 4]
Phase 4 trial of aripiprazole for schizophrenia with co-morbid social anxiety completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder [Phase 4]
Phase 4 trial results evaluating high-dose olanzapine for schizophrenia and schizoaffective disorder have been completed, according to the u…
-
CLINICAL_TRIALS research · 2006-12-27Clinical Trial Update: Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia [Phase 2]
Phase 2 multicenter trial in Israel is evaluating D-Serine for schizophrenia and schizoaffective disorder. The current trial status is unkno…
-
FDA approval · 2006-10-20FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2006-09-20FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for SEROQUEL (quetiapine) filed by H2-Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: A Comparative Study of New Medications for Psychosis in Adolescents [NA]
This clinical trial update reports the completion of a comparative study evaluating new medications for psychosis in adolescents. The study …
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Pharmacokinetic Characterization of Intramuscular Olanzapine Depot [Phase 1]
Phase 1 clinical trial update characterizing the pharmacokinetics of intramuscular olanzapine depot (olanzapine pamoate) in schizophrenia an…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia [Phase 4]
A Phase 4 trial comparing olanzapine to an active comparator in depression associated with schizophrenia has completed.